HempMeds Brasil subsidiary of Medical Marijuana, Inc. (OTC:MJNA) is sponsoring the Brazilian Society of Weight problems Drugs’s first Weight problems Drugs Symposium on March 3-6.
The symposium, which is able to happen on the Centro South Conference Middle in Santa Catarina, is designed to unite educators, wellness organizations and medical professionals to debate new methods and technological developments in weight problems medication.
“It is a nice alternative for us to teach folks on what CBD is, its potential wellness advantages, and the present analysis that’s being carried out on how CBD can be utilized by folks around the globe,” stated Matheus Patelli, HempMeds Brasil managing director. “CBD might be legally imported in Brazil and is backed by the Brazilian authorities for a lot of indications so that folks ought to perceive how and why they need to be taking it.”
Along with sponsoring the occasion, HempMeds Brasil shall be internet hosting a presentation on the symposium on March 4 about medical hashish and CBD together with the number of merchandise that exist in Brazil, wellness purposes in addition to legality and security data.
“Now we have skilled distinctive operational and income progress in Brazil over the previous few years and our invitation to sponsor this occasion is a testomony to our sturdy model presence there,” acknowledged Medical Marijuana, Inc. CEO Blake Schroeder. “In partnership with a few of Brazil’s most prestigious docs and researchers, we’ve created long-lasting relationships with Brazilian shoppers based mostly upon transparency, training, and belief.”
